ホーム>>Analytical Standards>> Reference Materials>>25H-NBOMe (hydrochloride)

25H-NBOMe (hydrochloride) (Synonyms: 2C-H-NBOMe)

カタログ番号GC42103

25H-NBOMeは、メスカリンと2C-BのフェネチルアミンのN-ベンジルアナログであり、ラットおよび人間のセロトニン5-HT2A受容体に対するアゴニストであり、それぞれKi値が1.19および2.83 nMです。

Products are for research use only. Not for human use. We do not sell to patients.

25H-NBOMe (hydrochloride) 化学構造

Cas No.: 1566571-52-5

サイズ 価格 在庫数 個数
1mg
$101.00
在庫あり
5mg
$253.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

25H-NBOMe, an N-benzyl analog of the phenethylamines mescaline and 2C-B, is an agonist for the rat and human serotonin 5-HT2A receptors with Ki values of 1.19 and 2.83 nM, respectively. In an in vitro activity assay, 25H-NBOMe demonstrates EC50 values of 81.2 and 15.3 nM for the rat and human serotonin 5-HT2A receptors, respectively. This product is intended for research and forensic applications. This product is a qualified Reference Material (RM) that has been manufactured and tested to meet ISO17025 and Guide 34 guidelines. These materials are tested using validated analytical methods on qualified instrumentation to ensure traceability of measurements. All traceable RMs may be distinguished by their CofAs and can be downloaded below using the batch number located on the product label. For a representative CofA please contact our technical support.

レビュー

Review for 25H-NBOMe (hydrochloride)

Average Rating: 5 ★★★★★ (Based on Reviews and 13 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 25H-NBOMe (hydrochloride)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.